1. Home
  2. FATE vs ZJYL Comparison

FATE vs ZJYL Comparison

Compare FATE & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • ZJYL
  • Stock Information
  • Founded
  • FATE 2007
  • ZJYL 2006
  • Country
  • FATE United States
  • ZJYL China
  • Employees
  • FATE N/A
  • ZJYL N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • ZJYL Industrial Specialties
  • Sector
  • FATE Health Care
  • ZJYL Consumer Discretionary
  • Exchange
  • FATE Nasdaq
  • ZJYL Nasdaq
  • Market Cap
  • FATE 116.5M
  • ZJYL 111.3M
  • IPO Year
  • FATE 2013
  • ZJYL 2023
  • Fundamental
  • Price
  • FATE $0.96
  • ZJYL $0.63
  • Analyst Decision
  • FATE Hold
  • ZJYL
  • Analyst Count
  • FATE 6
  • ZJYL 0
  • Target Price
  • FATE $3.30
  • ZJYL N/A
  • AVG Volume (30 Days)
  • FATE 1.4M
  • ZJYL 341.2K
  • Earning Date
  • FATE 11-11-2025
  • ZJYL 08-20-2025
  • Dividend Yield
  • FATE N/A
  • ZJYL N/A
  • EPS Growth
  • FATE N/A
  • ZJYL N/A
  • EPS
  • FATE N/A
  • ZJYL 0.01
  • Revenue
  • FATE $8,470,000.00
  • ZJYL $22,826,624.00
  • Revenue This Year
  • FATE N/A
  • ZJYL N/A
  • Revenue Next Year
  • FATE N/A
  • ZJYL N/A
  • P/E Ratio
  • FATE N/A
  • ZJYL $55.25
  • Revenue Growth
  • FATE N/A
  • ZJYL 13.42
  • 52 Week Low
  • FATE $0.66
  • ZJYL $0.50
  • 52 Week High
  • FATE $4.20
  • ZJYL $4.08
  • Technical
  • Relative Strength Index (RSI)
  • FATE 40.20
  • ZJYL 45.53
  • Support Level
  • FATE $0.93
  • ZJYL $0.57
  • Resistance Level
  • FATE $1.08
  • ZJYL $0.72
  • Average True Range (ATR)
  • FATE 0.06
  • ZJYL 0.08
  • MACD
  • FATE -0.01
  • ZJYL -0.01
  • Stochastic Oscillator
  • FATE 11.22
  • ZJYL 27.14

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

Share on Social Networks: